Aims and Scope
EMBO Molecular Medicine is a peer-reviewed, open access online journal dedicated to a new research discipline at the interface between clinical research and basic biology. It offers clinicians and researchers in this area the opportunity to publish their bestwork in a broadly distributed and highly visible forum, thereby lending a strong impetus to this important and rapidly developing field and helping to forge new links between clinicians and molecular biologists. Studies based on model organisms also fall within the scope of the journal, provided that the results presented are evidently and directly relevant to human disease. EMBO Molecular Medicine publishes research articles as full-length research papers and short reports. In addition, the journal publishes editorials and review articles in innovative formats that target a broad and non-specialized audience. For further information visit http://www.embomolmed.org.
EMBO Molecular Medicine is now part of the Wiley Open Access publishing programof fully open access journals published byWiley. For further information visit the Wiley Open Access website at http://www.wileyopenaccess.com.
Open Access and Copyright
All articles published by EMBO Molecular Medicine are fully open access: immediately freely available to read, download and share. All EMBO Molecular Medicine articles accepted from 14 August 2012 are published under the terms of the Creative Commons Attribution 3.0 Unported (CC BY 3.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Articles accepted before this date were published under the agreement as stated in the final article. Copyright on any EMBO Molecular Medicine article accepted after 7 March 2012, the date on which EMBO Molecular Medicine became an open access journal, is retained by the author(s). Authors grant toEMBOandWiley a license to publish the article and for Wiley to identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified.
Use by commercial “for-profit” organisations (not applicable to CC BY 3.0 licensed articles)
Use of Wiley Open Access articles for commercial, promotional, or marketing purposes requires further explicit permission from Wiley andwill be subject to a fee. Requests to reproducematerial fromthis journal content are being handled through the Rightslink® online service.
Locate the article you wish to reproduce on Wiley Online Library (http://onlinelibrary.wiley.com)
Navigate to the abstract page
Click on the ‘Request Permissions’ link, under the ‘ARTICLE TOOLS’ menu
Follow the online instructions and select your requirements from the drop down options and click on ‘quick price’ to get a quote
Create a RightsLink® account to complete your transaction (and pay, where applicable)
Read and accept our Terms & Conditions and Download your license
For any technical queries please contact customercare@copyright.com
For further information and to view a Rightslink® demo please visit http://www.wiley.com and select Rights & Permissions.
Special requests should be addressed to rightsDE@wiley.com. Print reprints of Wiley Open Access articles can be purchased from corporatesalesDE@wiley.com.
Disclaimer
The Publisher and Editors cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; the views and opinions expressed do not necessarily reflect those of the Publisher and Editors, neither does the publication of advertisements constitute any endorsements by the Publisher and Editors of the products advertised. Wiley Open Access articles posted to repositories or websites are without warranty from Wiley of any kind, either express or implied, including, but not limited to, warranties of merchantability, fitness for a particular purpose, or non-infringement. To the fullest extent permitted by lawWiley disclaims all liability for any loss or damage arising out of, or in connection, with the use of or inability to use the content